Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia

Circulation

Volumn 131, Issue 8, 2015, Pages 730-741

  Iriyama, Takayuki ^a,b   Sun, Kaiqi ^a,c   Parchim, Nicholas F ^a,c   Li, Jessica ^a   Zhao, Cheng ^a,d   Song, Anren ^a   Hart, Laura A ^a   Blackwell, Sean C ^a   Sibai, Baha M ^a   Chan, Lee Nien L ^e   Chan, Teh Sheng ^e   Hicks, M John ^f   Blackburn, Michael R ^a,c   Kellems, Rodney E ^a,c   Xia, Yang ^a,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TEXAS   (United States)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e University of Texas Medical Branch School of Medicine   (United States)

^f Texas Children's Hospital   (United States)

Author keywords

Adenosine; Animal; Hypertension; Models; Preeclampsia; Pregnancy

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A2B RECEPTOR; ADENOSINE DEAMINASE; ADENOSINE RECEPTOR; AUTOANTIBODY; VASCULOTROPIN RECEPTOR 1; FLT1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; FETUS; FETUS LIVER; GENE DELETION; GENE EXPRESSION; GENOTYPE; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PLACENTA; PLACENTA CIRCULATION; PLACENTA DISORDER; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; ADULT; ANIMAL; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; FETAL GROWTH RETARDATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION; UPREGULATION;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE DEAMINASE; ADULT; ANIMALS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; FEMALE; FETAL GROWTH RETARDATION; GENE DELETION; HUMANS; MICE, KNOCKOUT; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ADENOSINE A2B; SIGNAL TRANSDUCTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84923683461     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.013740     Document Type: Article

References (36)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-644. doi: 10.1016/S0140-6736(10)60279-6.
2. Xia Y, Kellems RE. Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond. Circ Res. 2013;113:78-87. doi: 10.1161/CIRCRESAHA.113.300752.
3. Georgiades P, Ferguson-Smith AC, Burton GJ. Comparative developmental anatomy of the murine and human definitive placentae. Placenta. 2002;23:3-19. doi: 10.1053/plac.2001.0738.
4. Thornburg KL, Louey S. Uteroplacental circulation and fetal vascular function and development. Curr Vasc Pharmacol. 2013;11:748-757.
5. Dilworth MR, Sibley CP. Review: transport across the placenta of mice and women. Placenta. 2013;34(suppl):S34-S39. doi: 10.1016/j.placenta.2012.10.011.
6. Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes. 2011;18:409-416. doi: 10.1097/MED.0b013e32834c800d.
7. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5:173-192. doi: 10.1146/annurev-pathol-121808-102149.
8. Ahmed A, Rahman M, Zhang X, Acevedo CH, Nijjar S, Rushton I, Bussolati B, St John J. Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med. 2000;6:391-409.
9. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation. 2007;115:1789-1797. doi: 10.1161/CIRCULATIONAHA.106.660134.
10. Wang K, Ahmad S, Cai M, Rennie J, Fujisawa T, Crispi F, Baily J, Miller MR, Cudmore M, Hadoke PW, Wang R, Gratacos E, Buhimschi IA, Buhimschi CS, Ahmed A. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation. 2013;127:2514-2522. doi: 10.1161/CIRCULATIONAHA.113.001631.
11. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658. doi: 10.1172/JCI17189.
12. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004;95:884-891. doi: 10.1161/01.RES.0000147365.86159.f5.
13. Lynch AM, Salmon JE. Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta. 2010;31:561-567. doi: 10.1016/j.placenta.2010.03.010.
14. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med. 2008;14:855-862. doi: 10.1038/nm.1856.
15. Chen JF, Eltzschig HK, Fredholm BB. Adenosine receptors as drug targets: what are the challenges? Nat Rev Drug Discov. 2013;12:265-286. doi: 10.1038/nrd3955.
16. Karmouty-Quintana H, Xia Y, Blackburn MR. Adenosine signaling during acute and chronic disease states. J Mol Med (Berl). 2013;91:173-181. doi: 10.1007/s00109-013-0997-1.
17. Zhang Y, Xia Y. Adenosine signaling in normal and sickle erythrocytes and beyond. Microbes Infect. 2012;14:863-873. doi: 10.1016/j.micinf.2012.05.005.
18. Zhou Y, Schneider DJ, Blackburn MR. Adenosine signaling and the regulation of chronic lung disease. Pharmacol Ther. 2009;123:105-116. doi: 10.1016/j.pharmthera.2009.04.003.
19. Zhang Y, Dai Y, Wen J, Zhang W, Grenz A, Sun H, Tao L, Lu G, Alexander DC, Milburn MV, Carter-Dawson L, Lewis DE, Zhang W, Eltzschig HK, Kellems RE, Blackburn MR, Juneja HS, Xia Y. Detrimental effects of adenosine signaling in sickle cell disease. Nat Med. 2011;17:79-86. doi: 10.1038/nm.2280.
20. Mi T, Abbasi S, Zhang H, Uray K, Chunn JL, Xia LW, Molina JG, Weisbrodt NW, Kellems RE, Blackburn MR, Xia Y. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest. 2008;118:1491-1501. doi: 10.1172/JCI33467.
21. Yoneyama Y, Suzuki S, Sawa R, Yoneyama K, Power GG, Araki T. Increased plasma adenosine concentrations and the severity of preeclampsia. Obstet Gynecol. 2002;100:1266-1270.
22. Espinoza J, Espinoza AF, Power GG. High fetal plasma adenosine concentration: a role for the fetus in preeclampsia? Am J Obstet Gynecol. 2011;205:485.e24-485.e27. doi: 10.1016/j.ajog.2011.06.034.
23. Yoneyama Y, Suzuki S, Sawa R, Yoneyama K, Power GG, Araki T. Relation between adenosine and T-helper 1/T-helper 2 imbalance in women with preeclampsia. Obstet Gynecol. 2002;99:641-646.
24. Matsubara S, Sato I. Plasma adenosine levels and P-selectin expression on platelets in preeclampsia. Obstet Gynecol. 2001;98:354-355.
25. George EM, Cockrell K, Adair TH, Granger JP. Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am J Physiol Regul Integr Comp Physiol. 2010;299:R1629-R1633. doi: 10.1152/ajpregu.00330.2010.
26. Blackburn MR, Datta SK, Kellems RE. Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J Biol Chem. 1998;273: 5093-5100.
27. Blackburn MR, Wakamiya M, Caskey CT, Kellems RE. Tissue-specific rescue suggests that placental adenosine deaminase is important for fetal development in mice. J Biol Chem. 1995;270:23891-23894.
28. Roberts JM, Pearson G, Cutler J, Lindheimer M; NHLBI Working Group on Research on Hypertension During Pregnancy. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension. 2003;41:437-445. doi: 10.1161/01.HYP.0000054981.03589.E9.
29. Migchielsen AA, Breuer ML, van Roon MA, te Riele H, Zurcher C, Ossendorp F, Toutain S, Hershfield MS, Berns A, Valerio D. Adenosine-deaminase-deficient mice die perinatally and exhibit livercell degeneration, atelectasis and small intestinal cell death. Nat Genet. 1995;10:279-287. doi: 10.1038/ng0795-279.
30. Wakamiya M, Blackburn MR, Jurecic R, McArthur MJ, Geske RS, Cartwright J Jr, Mitani K, Vaishnav S, Belmont JW, Kellems RE, Finegold MJ, Montgomery CA Jr, Bradley A, Caskey CT. Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc Natl Acad Sci U S A. 1995;92:3673-3677.
31. LaMarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep. 2007;9:480-485.
32. Zhang W, Zhang Y, Wang W, Dai Y, Ning C, Luo R, Sun K, Glover L, Grenz A, Sun H, Tao L, Zhang W, Colgan SP, Blackburn MR, Eltzschig HK, Kellems RE, Xia Y. Elevated ecto-5′-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circ Res. 2013;112:1466-1478. doi: 10.1161/CIRCRESAHA.111.300166.
33. Yoneyama Y, Sawa R, Suzuki S, Doi D, Yoneyama K, Otsubo Y, Araki T. Relationship between plasma malondialdehyde levels and adenosine deaminase activities in preeclampsia. Clin Chim Acta. 2002;322:169-173.
34. Kafkasli A, Karabulut AB, Atmaca R, Laurini R. Clinical correlation between adenosine deaminase activity and pre-eclampsia severity. J Int Med Res. 2006;34:247-255.
35. Johnston JM, Kredich NM. Inhibition of methylation by adenosine in adenosine deaminase-inhibited, phytohemagglutinin-stimulated human lymphocytes. J Immunol. 1979;123:97-103.
36. Kredich NM, Hershfield MS. S-Adenosylhomocysteine toxicity in normal and adenosine kinase-deficient lymphoblasts of human origin. Proc Natl Acad Sci U S A. 1979;76:2450-2454.